ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation

Clinical and Experimental Metastasis

Volumn 17, Issue 8, 1999, Pages 649-654

  Seddighzadeh, Maria ^a   Zhou, Jian Nian ^a   Kronenwett, Ulrike ^a   Shoshan, Maria C ^a   Auer, Gert ^a   Sten Linder, Margareta ^a   Wiman, Björn ^a   Linder, Stig ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Breast cancer; Cyclin D1; ERK; u PA

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLIN D1; CYCLIN DEPENDENT KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OKADAIC ACID; PROTEIN P21; UROKINASE;

ARTICLE; BREAST CARCINOMA; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; METASTASIS; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL DIVISION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM METASTASIS; OKADAIC ACID; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-JUN; PROTO-ONCOGENE PROTEINS C-RAF; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0033361269     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006741228402     Document Type: Article

References (34)

1. 1. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991; 51: 5054s-9s.
2. 2. Mignatti P, Rifkin DB. Biology and biochemistry of proteases in tumor invasion. Physiol Rev 1993; 73: 161-95.
3. 3. Lindblom A, Linder S. The metastatic phenotype - prognostic implications. Crit Rev Oncol/Hematol 1996; 24: 71-96.
4. 4. Carmeliet P, Schoonjans L, Kieckens L et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368: 419-24.
5. 5. Andreasen P-A, Kjoøller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: A review. Int J Cancer 1997; 72: 1-22.
6. 6. Reuning U, Magdolen V, Wilhelm O et al. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis. Int J Ontol 1998; 13: 893-906.
7. 7. Lengyel E, Stepp E, Gum R et al. J Biol Chem 1995; 270: 23007-12.
8. 8. Lengyel E, Gum R, Stepp E et al. Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras. Cell Biochem 1996; 61: 430-43.
9. 9. Watabe T, Yoshida K, Shindoh M et al The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int J Cancer 1998; 77: 128-37.
10. 10. Janulis M, Silberman S, Ambegaokar A et al. Role of mitogen-activated protein kinases and c-Jun/AP-1 trans-activating activity in the regulation of protease mRNAs and the malignant phenotype in NIH 3T3 fibroblasts. J Biol Chem 1999; 274: 801-13.
11. 11. Davis RJ. Transcriptional regulation by MAP kinases. Mol Reprod Dev 1995; 42: 459-67.
12. 12. Woodgett JR, Avruch J, Kyriakis J. The stress activated protein kinase pathway. Cancer Surv 1996; 27: 127-38.
13. 13. Russell M, Lange-Carter CA, Johnson GL. Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1). J Biol Chem 1995; 270: 11757-60.
14. 14. Ghiso JAA, Alonso DF, Farias EF et al. Deregulation of the signaling pathways controlling urokinase production - its relationship with the invasive phenotype. Eur J Biochem 1999; 263: 295-304.
15. 15. Holst-Hansen C, Johannessen B, Hoyer-Hansen G et al. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness. Clin Exp Metastasis 1996; 14: 297-307.
16. 16. Thompson EW, Paik S, Brunner N et al. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992; 150: 534-54.
17. 17. Lee FS, Hagler J, Chen ZJ, Maniatis T. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell 1997; 88: 213-222.
18. 18. Molin M, Shoshan MC, Öhman K et al. Two novel adenovirus vector systems permitting regulated protein expression in gene transfer experiments. J Virol 1998; 72: 8358-61.
19. 19. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996; 6: 986-94.
20. 20. Zhou JN, Ljungdahl S, Shoshan M et al. Activation of tissue factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signalling pathway. Mol Carcinogen 1998; 21: 234-43.
21. 21. Pages G, Lenormand P, L'Allemain G et al. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA 1993; 90: 8319-23.
22. 22. Liu J-J, Chao J-R, Jiang M-C et al. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progresison in NIH 3T3 cells. Mol Cell Biol 1995; 15: 3654-63.
23. 23. Lloyd AC, Obermüller F, Staddon S et al. Co-operating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev 1997; 11: 663-77.
24. 24. Sewing A, Wiseman B, Lloyd AC, Land H. High intensity Raf signaling causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol 1997; 17: 5588-97.
25. 25. Alblas J, Slager-Davidov R, Steenbergh PH et al. The role of MAP kinase in TPA-mediated cell cycle arrest of human breast cancer cells. Oncogene 1998; 16: 131-9.
26. 26. D'Orazio D, Besser D, Marksitzer R et al. Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2. Gene 1997; 201: 179-87.
27. 27. Miralles F, Parra M, Caelles C et al. UV irradiation induces the murine urokinase-type plasminogen activator gene via the c-Jun N-terminal kinase signaling pathway: Requirement of an AP-1 enhancer element. Mol Cell Biol 1998; 18: 4537-47.
28. 28. Xing RH, Rabbiani SA. Transcriptional regulation of urokinase (uPA) gene expression in breast cancer cells: role of DNA methylation. Int J Cancer 1999; 81: 443-50.
29. 29. Ljungdahl S, Linder S, Sollerbrandt K et al. Signal transduction in fibroblasts stably transformed by [Val12]Ras. The activities of extracellular-signal-regulated kinase and Jun-N-terminal kinase are only moderately increased, and the activity of the δ-inhibitor of c-Jun is not alleviated. Eur J Biochem 1997; 249: 648-56.
30. 30. Ravi RK, Weber E, McMahon M et al. Activated Raf-1 causes growth arrest in human small cell lung cancer cells. J Clin Invest 1998; 101: 153-9.
31. 31. Hazzalin CA, Cuenda A, Cano E et al. Effects of the inhibition of p38/RK MAP kinase on induction of live fos and jun genes by diverse stimuli. Oncogene 1997; 15: 2321-31.
32. 32. Tombes RM, Auer KL, Mikkelsen R et al. The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. Biochem J 1998; 330: 1451-60.
33. 33. Irigoyen JP, Besser D, Nagamine Y. Cytoskeleton reorganization induces the urokinase-type plasminogen activator gene via the Ras/extracellular signal-regulated kinase (ERK) signaling pathway. J Biol Chem 1997; 272: 1904-9.
34. 34. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179-85.